Company / Gross Margin
Sanara MedTech Inc. Gross Margin History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
90.6%
FY2025
5-year range
86.1% / 90.6%
FY2021-FY2025
Trend
+3.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin has fluctuated over the past 10 years, ranging from 69.5% in FY2015 to 90.6% in FY2025.
Based on SEC 10-K filings.
90.6% in FY2025 with a 10-year CAGR of +21.1%.
Improved from 86.1% to 90.6% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- +0.2pp
- 5-Year Change
- +0.9pp
- 10-Year Change
- +21.1pp
Key checks
Key Insights
- In FY2025, gross margin increased 3.1% year-over-year.
- Lowest gross margin in the period was in FY2015.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 90.6% | +3.1% |
| FY2024 | 87.9% | +2.1% |
| FY2023 | 86.1% | -4.8% |
| FY2022 | 90.4% | +0.9% |
| FY2021 | 89.6% | -0.1% |
| FY2020 | 89.7% | +2.9% |
| FY2018 | 87.2% | +5.2% |
| FY2017 | 82.9% | +12.7% |
| FY2016 | 73.6% | +5.9% |
| FY2015 | 69.5% | +28.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026